Robust sustained release formulations

Details for Australian Patent Application No. 2006349402 (hide)

Owner Penwest Pharmaceuticals Co.

Inventors Fitzmaurice, Kevin; Labudzinski, Steve; Baichwal, Anand R.

Agent Davies Collison Cave

Pub. Number AU-A-2006349402

PCT Pub. Number WO2008/045060

Filing date 10 October 2006

Wipo publication date 17 April 2008

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045060 Priority application(s): WO2008/045060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006349436-Constant-velocity drive system for gimbaled rotor hubs

2006349377-Botulinum nanoemulsions